NEURENTIS(UK) LTD
Company number 12566764 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£100,111
Balance sheet as at 2025-04-30
What it does
The principal activity of the company is dormant
The company's own description, from its latest filed accounts.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2020-04-21
- Employees
- 1 (2025 accounts)
- Registered office
- Flat 47 Ashworth Mansions, Grantully Road, London, England, W9 1LW
- Postcode
- W9 1LW
- Capital
- 111 GBP
- Accounts category
- Micro
Accounts
- Last made up to
- 2025-04-30
- Next due by
- 2027-01-31
- Financial year end
- 30 April
Confirmation statement
- Last statement dated
- 2026-05-24
- Next due by
- 2027-06-07
Nature of business (SIC)
- 1280 Growing of spices, aromatic, drug and pharmaceutical crops
- 86900 Other human health activities
Officers 1 current
DR Stephane Robert, Dr MERY
Director
Contact details
- Website
- neurentis.com
- Phone
- +44 2032393022
Committed to improving mental health through cutting-edge research & innovative drug development.
Previous company names
| Name | Date changed |
|---|---|
| AKESI HEALTH LTD | 2024-10-17 |
Among its peers
Top 25%
by shareholders' funds, of 173 similar companies in W — measured against the wider sector
Trading since 2020.
The class of 2020
32%
of the 775,734 companies incorporated in 2020 are still active today; 65% have since been dissolved.
A fact about the year, not a forecast for this company.